11.5
虚血性心疾患: 概要
虚血性心疾患は、心臓への血液供給が減少すると起こり、心筋への酸素と栄養の欠乏を引き起こします。血流の減少または閉塞から生じるこの欠乏は危険を伴い、心筋の損傷や機能不全につながります。
この危険な状態を引き起こす主な原因として、動脈硬化症が有名です。動脈硬化症は、動脈壁内に潜行性プラークに似た脂肪沈着…
虚血性心疾患は、心臓への血液供給が減少または閉塞したときに発生します。これにより、酸素と栄養素の供給が不十分になり、心筋の損傷や機能障害につながります。
この状態は主に、動脈壁内の脂肪沈着物またはプラークの蓄積であるアテローム性動脈硬化症によって引き起こされます。
時間が経つにつれて、これらのプラークは動脈を硬化させて狭くし、血流を制限する可能性があります。
場合によっては、プラークが破裂し、血栓の形成を引き起こして冠状動脈をさらに閉塞させ、狭心症、心筋梗塞、心不全、または心臓突然死につながる可能性があります。
虚血性心疾患の危険因子には、年齢、性別、家族歴、喫煙、高血圧とコレステロール、肥満、糖尿病、ストレスなどがあります。
この病気は、ライフスタイルの変更や、アスピリン、ACE阻害剤、有機硝酸塩、β遮断薬などの薬によって管理できます。
より重症の場合、心臓への適切な血流を回復するために、血管形成術やバイパス手術などの侵襲的な処置が必要になる場合があります。
View the full transcript and gain access to JoVE Core videos
Q1: What causes ischemic heart disease?
Ischemic heart disease results from reduced or obstructed blood supply to the heart, causing insufficient oxygen and nutrient delivery. Atherosclerosis is the primary cause, involving accumulation of fatty deposits and plaques within arterial walls. Over time, these plaques harden and narrow arteries, restricting blood flow and potentially triggering clot formation that further obstructs coronary arteries.
Q2: What are the main complications of ischemic heart disease?
Ischemic heart disease can lead to serious complications including angina, myocardial infarction, heart failure, and sudden cardiac death. These complications occur when plaque ruptures and forms a clot that blocks the coronary artery, severely restricting blood flow to the heart muscle and causing damage or dysfunction.
Q3: Which risk factors increase susceptibility to ischemic heart disease?
Multiple risk factors contribute to ischemic heart disease development, including age, gender, family history, smoking, high blood pressure, elevated cholesterol, obesity, diabetes, and stress. These factors work together to increase the likelihood of atherosclerosis development and plaque formation within coronary arteries.
Q4: How are medications used to manage ischemic heart disease?
Medications such as aspirin, ACE inhibitors, organic nitrates, and beta-blockers help manage ischemic heart disease by reducing symptoms and preventing complications. Aspirin acts as an antiplatelet agent, while antianginal drugs like organic nitrates and beta-blockers improve blood flow and reduce cardiac workload, protecting heart tissue from ischemic damage.
Q5: When are invasive procedures necessary for ischemic heart disease?
Invasive procedures like angioplasty and bypass surgery become necessary in severe cases when lifestyle changes and medications cannot adequately restore blood flow. These procedures mechanically restore adequate blood supply to the heart muscle, preventing further damage and reducing the risk of myocardial infarction or sudden cardiac death.
Q6: What role do antiplatelet drugs play in ischemic heart disease treatment?
Antiplatelet drugs prevent clot formation by inhibiting platelet aggregation, reducing the risk of thrombosis in narrowed coronary arteries. These medications, including aspirin and antiplatelet drugs prostaglandin synthesis p2y12 and glycoprotein iib iiia inhibitors, are essential for preventing acute coronary events in patients with ischemic heart disease.
Q7: How do lifestyle modifications complement pharmacological treatment?
Lifestyle changes form the foundation of ischemic heart disease management alongside medications. Reducing smoking, controlling blood pressure and cholesterol, maintaining healthy weight, managing diabetes, and reducing stress help slow atherosclerosis progression and decrease overall cardiovascular risk, enhancing the effectiveness of pharmacological interventions.